Remote Patient Monitoring

DOES IT WORK FOR MY PRACTICE?

Healthcare is changing with recent advancements in technology based delivery systems that are designed to provide better patient care at lower costs, focused on outcomes. Remote Patient Monitoring (RPM) is part of that change.

CMS started in 2018 reimbursing for RPM services that are defined by communication technologies that are not defined by restrictions previously defining Telehealth services found in Section 1834(m) of the Social Security Act.

Remote Patient Monitoring solutions are driven by increased healthcare costs, increased prevalence of chronic diseases and shortage of healthcare professionals. Around 9 out of 10 health systems and hospitals have adopted RPM or are in the process of doing so.

RPM is designed to offer better care at lower costs with particular focus on chronic diseases such as hypertension, diabetes, COPD and Congestive Heart Failure (CHF), all of which are directly linked to poor Sleep Quality or untreated / unsuccessfully treated sleep disorders.

SleepImage analysis is based on measuring parasympathetic activation during sleep, a key factor to optimize chronic disease management by offering relevant data collected for about ⅓ of every 24 hours on average, with reported biomarkers that go beyond sleep apnea management.

The SleepImage Sleep Quality Index has demonstrated significant negative correlation with Blood Pressure Control in Patients with Cardiovascular Disease and OSA (SQI increases with dropping BP).

The SleepImage Sleep Quality Index has demonstrated significant correlation with Average Heart Rate during sleep, Insulin and Triglyceride levels, even in Healthy Weight Children.

The SleepImage biomarker of Fragmentation has demonstrated significant agreement with arousals from PSG, even in Healthy Weight Children. Fragmentation has an established relationship with cardio-metabolic and biochemical measures, including, but not limited to triglycerides, insulin, glucose and blood pressure.

The SleepImage biomarker of Periodicity has been significantly associated with risk of fatality in CHF Patients. Periodicity may be an effective biomarker to track the need for and timing of intervention management for CHF patients.

The SleepImage System measures coupling of Heart Rate Variability and Respiration from a single-sensor technology that can easily be applied by patients in their home on a regular basis at low cost.

Initial set up and patient education on use of device.

Reimbursement ≈$20 (one-time)*

*SleepImage does not offer advice on RPM applicability or reimbursement rates.

Supply of devices, data collection, transmission, and report summary services to the clinician.

Reimbursement ≈$64 (Each 30 days with capability of daily recordings, using a medical device as defined by the FDA)*

*SleepImage does not offer advice on RPM applicability or reimbursement rates.

Remote physiological monitoring services by clinical staff under general supervision (MD / QHCP) for the first 20 minutes of interactive patient communication in a calendar month.

Reimbursement ≈$51*

*SleepImage does not offer advice on RPM applicability or reimbursement rates.

Remote physiological monitoring services by clinical staff under general supervision (MD / QHCP) for each subsequent 20 minutes of interactive patient communication in a calendar month.

Reimbursement ≈$42*

*SleepImage does not offer advice on RPM applicability or reimbursement rates.

Contact Us